| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| NOVO-B.CO - Novo Nordisk A/S | BUY | 10,287 @ DKK 60.8193 | DKK 625,648 | The ETF bought 10287 new shares of NOVO-B.CO (Novo Nordisk A/S). The shares were bought for an average price of 60.8193 compared to the previous average buy price of 67.2163. This is -9.5% lower than average price of previous purchases of NOVO-B.CO. |
| GMAB.CO - | BUY | 624 @ DKK 184.945 | DKK 115,406 | The ETF bought 624 new shares of GMAB.CO (). The shares were bought for an average price of 184.945 compared to the previous average buy price of 191.511. This is -3.4% lower than average price of previous purchases of GMAB.CO. |
| COLO-B.CO - | BUY | 333 @ DKK 85.2127 | DKK 28,376 | The ETF bought 333 new shares of COLO-B.CO (). The shares were bought for an average price of 85.2127 compared to the previous average buy price of 95.4029. This is -10.7% lower than average price of previous purchases of COLO-B.CO. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 117 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 117. The average price that BIM.PA shares were previous bought at was EUR 109.561. The current market price is 6.8% higher than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 9,632 (USD $10,920) compared to the previous valuation of BioMerieux |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 51.24 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 51.24. The average price that FME.DE shares were previous bought at was EUR 45.1945. The current market price is 13.4% higher than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 72,742 (USD $82,468) compared to the previous valuation of Fresenius Medical Care AG |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 56.74 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 56.74. The average price that ERF.PA shares were previous bought at was EUR 50.2178. The current market price is 13.0% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 11,421 (USD $12,948) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-05-28 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 219.2 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 219.2. The average price that SRT3.DE shares were previous bought at was EUR 223.287. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 21,191 (USD $24,024) compared to the previous valuation of Sartorius AG |
| SOBI.ST - | HOLD | 0 @ SEK 26.955 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 26.955. The average price that SOBI.ST shares were previous bought at was SEK 26.8963. The current market price is 0.2% higher than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 6,158 (USD $640) compared to the previous valuation of |
| GALD.SW - | HOLD | 0 @ CHF 112.34 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 112.34. The average price that GALD.SW shares were previous bought at was CHF 97.4314. The current market price is 15.3% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 17,272 (USD $20,879) compared to the previous valuation of however if the holding was sold on 2025-05-28 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 192.8 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 192.8. The average price that DIM.PA shares were previous bought at was EUR 190.027. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 14,594 (USD $16,545) compared to the previous valuation of Sartorius Stedim Biotech |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 51.8 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 51.8. The average price that REC.MI shares were previous bought at was EUR 52.4787. The current market price is -1.3% lower than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 57.95 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 57.95. The average price that ORNBV.HE shares were previous bought at was EUR 49.2948. The current market price is 17.6% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 20,878 (USD $23,670) compared to the previous valuation of Orion Oyj |
| RO.SW - | HOLD | 0 @ CHF 296.647 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 296.647. The average price that RO.SW shares were previous bought at was CHF 302.837. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 13,425 (USD $16,228) compared to the previous valuation of |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 103.1 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 103.1. The average price that IPN.PA shares were previous bought at was EUR 107.743. The current market price is -4.3% lower than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 2,890 (USD $3,276) compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-05-28 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 25.6013 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 25.6013. The average price that HIK.L shares were previous bought at was GBP 24.2938. The current market price is 5.4% higher than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 26,971 (USD $36,447) compared to the previous valuation of however if the holding was sold on 2025-05-28 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 9.45 | EUR 0 | |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 19.97 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 19.97. The average price that AMP.MI shares were previous bought at was EUR 22.68. The current market price is -11.9% lower than average price they were purchased at. The value of the holding in AMP.MI has increased by EUR 1,442 (USD $1,635) compared to the previous valuation of Amplifon SpA however if the holding was sold on 2025-05-28 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 91.04 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 91.04. The average price that DIA.MI shares were previous bought at was EUR 66.4761. The current market price is 37.0% higher than average price they were purchased at. The value of the holding in DIA.MI has fallen by EUR 4,895 (USD $5,550) compared to the previous valuation of DiaSorin SpA |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 39.145 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 39.145. The average price that QIA.DE shares were previous bought at was EUR 36.9082. The current market price is 6.1% higher than average price they were purchased at. The value of the holding in QIA.DE has increased by EUR 42,831 (USD $48,558) compared to the previous valuation of QIAGEN NV however if the holding was sold on 2025-05-28 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.94864 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.94864. The average price that HLN.L shares were previous bought at was GBP 4.68648. The current market price is 5.6% higher than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 74,729 (USD $100,984) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-05-28 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 154.8 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 154.8. The average price that UCB.BR shares were previous bought at was EUR 173.808. The current market price is -10.9% lower than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 169,208 (USD $191,833) compared to the previous valuation of UCB SA |
| NOVN.SW - | HOLD | 0 @ CHF 99.307 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 99.307. The average price that NOVN.SW shares were previous bought at was CHF 97.6741. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 448,879 (USD $542,609) compared to the previous valuation of |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 123.787 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 123.787. The average price that AZN.L shares were previous bought at was GBP 128.645. The current market price is -3.8% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 708,704 (USD $957,695) compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 92.62 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 92.62. The average price that SAN.PA shares were previous bought at was EUR 96.5074. The current market price is -4.0% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 78,270 (USD $88,735) compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 17.2404 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 17.2404. The average price that GSK.L shares were previous bought at was GBP 16.6578. The current market price is 3.5% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 34,258 (USD $46,294) compared to the previous valuation of GlaxoSmithKline PLC |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 247.6 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 247.6. The average price that EL.PA shares were previous bought at was EUR 249.611. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 636,631 (USD $721,755) compared to the previous valuation of EssilorLuxottica SA |
| LONN.SW - | HOLD | 0 @ CHF 601.004 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 601.004. The average price that LONN.SW shares were previous bought at was CHF 581.134. The current market price is 3.4% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 106,832 (USD $129,140) compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 75.5645 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 75.5645. The average price that ALC.SW shares were previous bought at was CHF 82.5763. The current market price is -8.5% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 224,658 (USD $271,569) compared to the previous valuation of |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 508.6 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 508.6. The average price that ARGX.BR shares were previous bought at was EUR 561.881. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 162,022 (USD $183,686) compared to the previous valuation of Argenx SE |
| ROG.SW - | HOLD | 0 @ CHF 278.655 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 278.655. The average price that ROG.SW shares were previous bought at was CHF 286.277. The current market price is -2.7% lower than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 114,329 (USD $138,202) compared to the previous valuation of however if the holding was sold on 2025-05-28 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 24.67 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 24.67. The average price that BAYN.DE shares were previous bought at was EUR 21.4418. The current market price is 15.1% higher than average price they were purchased at. The value of the holding in BAYN.DE has fallen by EUR 97,698 (USD $110,761) compared to the previous valuation of Bayer AG |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 20.33 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 20.33. The average price that PHIA.AS shares were previous bought at was EUR 23.6773. The current market price is -14.1% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 27,516 (USD $31,195) compared to the previous valuation of Koninklijke Philips NV |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 115.35 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 115.35. The average price that MRK.DE shares were previous bought at was EUR 132.952. The current market price is -13.2% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 81,632 (USD $92,547) compared to the previous valuation of Merck KGaA |
| SDZ.SW - | HOLD | 0 @ CHF 43.2547 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 43.2547. The average price that SDZ.SW shares were previous bought at was CHF 39.6366. The current market price is 9.1% higher than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 30,596 (USD $36,985) compared to the previous valuation of |
| SOON.SW - | HOLD | 0 @ CHF 275.978 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 275.978. The average price that SOON.SW shares were previous bought at was CHF 296.607. The current market price is -7.0% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 88,603 (USD $107,104) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 47.1 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 47.1. The average price that SHL.DE shares were previous bought at was EUR 50.3918. The current market price is -6.5% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 56,095 (USD $63,595) compared to the previous valuation of Siemens Healthineers AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 42.54 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 42.54. The average price that FRE.DE shares were previous bought at was EUR 36.9698. The current market price is 15.1% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 127,661 (USD $144,731) compared to the previous valuation of Fresenius SE & Co KGaA |
| STMN.SW - | HOLD | 0 @ CHF 114.75 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 114.75. The average price that STMN.SW shares were previous bought at was CHF 119.361. The current market price is -3.9% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 79,633 (USD $96,261) compared to the previous valuation of |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 12.6874 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 12.6874. The average price that SN.L shares were previous bought at was GBP 12.7565. The current market price is -0.5% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 31,277 (USD $42,266) compared to the previous valuation of Smith & Nephew PLC |
| DEMANT.CO - | SELL | -1,115 @ DKK 34.4551 | DKK -38,417 | The ETF sold 1115 shares of DEMANT.CO on 2025-05-28. The shares were previously bought for an average price of DKK 34.2927. The shares were sold for 0.5% higher than average price of previous purchases. This sale made a profit of DKK 181 (USD $28) The average price that the ETF previously sold DEMANT.CO share for is DKK 35.0591 which is higher than the selling price of DKK 34.4551 on 2025-05-28. |